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Abstract: Flavonoids constitute a large group of polyphenolic phytochemicals with 
antioxidant properties which are overwhelmingly exerted through direct free radical 
scavenging. Flavonoids also exhibit antioxidant properties through chelating with tran-
sition metals, primarily Fe(II), Fe(III) and Cu(II), which participate in reactions ge-
nerating free radicals. Metal–flavonoid chelates are considerably more potent free 
radical scavengers than the parent flavonoids and play a prominent role in protec-
ting from oxidative stress. To unravel the origin of their potent biological action ex-
tensive physico–chemical studies were undertaken to reveal the chemical structure, 
chelation sites, assess the impact of the metal/ligand ratio on the structure of the com-
plexes and the capacity of flavonoids to bind metal ions. In spite of such extensive 
efforts, data on the composition, structure and complex-formation properties are in-
complete and sometimes even contradictory. The aim of this paper is to give a per-
sonal account on the development of the field through a retrospective evaluation of 
our own research which covers approximately 40 complexes of flavonoids from dif-
ferent flavonoids subclasses (rutin, quercetin, 3-hydroxyflavone, morin and hespe-
ridin) with several metal ions or groups and suggest directions for future research. 
Special emphasis will be given to the site of the central ion, the composition of the 
complexes, the role of pH in complex formation, the stability of metal–flavonoid com-
plexes and their potential application for analytical purposes. 
Keywords: flavonoids, chelates, free radical scavengers, stability constants, quanti-
tative analysis. 
FLAVONOIDS 
The Hungarian Nobel laureate Albert Szent-Györgyi discovered flavonoid 
compounds in 1936.1 Using evidence from his own experiments, he hypothesized 
that a new vitamin – vitamin P works synergistically with vitamin C in citrus ex-
tracts to strengthen capillaries.2 Although the description of flavonoids as vita-
mins was eventually found to be inaccurate, research into their beneficial poten-
tials continued and has increased dramatically over the past two decades.36 
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Flavonoids (flavus – yellow), or bioflavonoids, are a ubiquitous group of po-
lyphenolic substances which are present in most plants, concentrated in the seeds, 
fruit skin or peel, bark and flowers.3 More than 4000 different flavonoids have 
been identified to date, making them the largest group of plant chemicals. Many 
fruits and vegetables, especially buckwheat, apple and onion, are some of these 
sources. Beverages prepared from plant extracts (beer, tea, wine, fruit juice) are 
the principal source of dietary flavonoid intake.7–16 
Health benefits of flavonoids 
Scientific studies conducted in the last few years generated a growing interest 
in the potentially important role of flavonoids in maintaining human health. A con-
siderable number of plant medicines contain flavonoids, which have been reported 
by many authors as having anti-bacterial, anti-inflammatory, anti-allergic, anti-mu-
tagenic, anti-viral, anti-neoplastic, anti-thrombotic, and vasodilatory actions.1731 
Overwhelmingly, the pharmacological effects are related to the anti-oxidant acti-
vity of flavonoids, arising through their ability to scavenge free radicals. When ge-
nerated in excess, free radicals can damage biomolecules, and are therefore impli-
cated in the etiology of several diseases and ageing.32 Radical scavenging by flavo-
noids occurs via electron donation from the free hydroxyls on the flavonoid nu-
cleus with the formation of a less reactive flavonoid aroxyl radical, which is stabi-
lized by resonance and therefore plays only a moderate role in the propagation of ra-
dical-induced damage in biological systems. The anti-oxidant activity of flavonoids 
correlates well with their physiological function in vivo, because oxidative stress is 
known to participate in the initial process of atherosclerosis leading to coronary heart 
disease and other patho-physiological events. A number of studies have revealed that 
flavonoids act as anti-oxidants by scavenging reactive oxygen species.3342 
Specifically, flavonoids reduce the risk of stroke and heart disease (the so-cal-
led French paradox, the lack of a positive correlation between a high intake of 
saturated fat and the occurrence of coronary heart disease is related at least partly 
to the consumption of red wine,43 which is rich in flavonoids), protect against 
age-related vision disorders, relieve hay fever, sinusitis, asthma symptoms, alle-
viate inflammatory skin conditions, reduce inflammation in joints and muscles, 
common to rheumatoid arthritis, minimize menopausal hot flushes, shrink he-
morrhoids, reduce varicose veins and battle viral infections.1731,44 
A considerable number of pharmaceutical preparations containing flavonoids 
as active substance are commercially available today. For example, Ginkgo bilo-
ba leaf extract,45 used in the treatment of symptoms in the early stages of Alz-
heimer's disease, vascular dementia and memory impairment,46 is the most wide-
ly sold phytomedicine in Europe. Some of the commercial pharmaceutical prepa-
rations which include the flavonoid rutin are widely used for curing veins disea-
ses. Quercetin, the most biologically active and common dietary flavonoid, is 
generally used as a dietary supplement. 
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Structure and spectral characteristics of flavonoids 
The carbon atoms in flavonoid molecules are assembled in two aromatic 
rings, commonly denoted as A and B, which are connected by a three-carbon 
“bridge”: C6–C3–C6, thus forming a diphenyl-propane structure with the central 
unit being a benzo--pyrone (chromone). Multiple hydroxyl groups, sugar, oxy-
gen, or methyl groups are attached to this core structure. Depending on the oxida-
tion state of the heterocyclic ring, flavonoids are classified as flavones, flavano-
nols, flavonols, flavanones or isoflavones (Fig. 1).3 
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Fig. 1. The flavonoid nucleus consists of benzo--pyrone (ring A and ring C) and benzene (ring B). 
The major classes of flavonoids are flavone, flavanonol, flavonol, flavanone and isoflavone. 
Being pigments responsible for the color of leaves, herbs and petals, flavo-
noids strongly absorb ultraviolet (UV) radiation. Therefore UV–Vis spectroscopy 
remains the main tool for structural analysis of flavonoids. Typically, two major 
absorption maxima are observed in the UV–Vis spectrum of flavonoids. The ab-
sorption maximum observed in the range 240–285 nm is referred to as band II 
and the one between 300–400 nm as band I. In general terms, absorption band II 
may be considered as originating from   * transitions in the A ring, a ben-
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zene system, whereas the absorption band I is attributed to transitions in the B 
ring, a cinnamoyl system. The position of band I in flavones is between 304–350 nm, 
while flavonols absorb in the range 352–385 nm. Highly oxygenated flavones 
and flavonols tend to absorb at longer wavelengths than those with fewer oxygen 
substituents. Methylation or glycosylation of the hydroxyl groups on the flavo-
noid nucleus usually results in hypsochromic shifts, predominantly of band I. The 
book by Marby5 provides a detailed catalogue of UV spectra of 175 flavonoids. 
METAL–FLAVONOID CHELATES 
Due to their specific chemical structure, flavonoids easily chelate metal ions 
and create complex compounds. 
Biological activity of metal–flavonoids complexes: chelates as free radical scavengers 
In addition to direct free radical scavenging, flavonoids exert anti-oxidant 
activity through interactions with the reduced form of transition metals, primarily 
Fe(II), Fe(III) and Cu(I), which participate in reactions generating free radicals.47 
Flavonoids may sequester metal ions by chelating and preventing metal-mediated 
generation of free radicals and, accordingly, may protect the potential biological 
targets from oxidative stress. Thus, the overall anti-oxidant action of flavonoids 
appears to be a combination of a direct reaction with free radicals and chelating 
the metal ions responsible for the production of reactive oxygen species. 
It was confirmed in numerous studies that flavonoids function as anti-oxi-
dants mainly by chelating metal ions.48–60 Moreover, experimental data have 
shown that the chelates are considerably more effective free radical scavengers 
than the free flavonoids. Kostyuk et al.56 found that complexes of rutin, dihydro-
quercetin or epicatechin with Fe(II), Fe(III), Cu(II) or Zn(II) are more effective ra-
dical scavengers than the free flavonoids, due to the acquisition of additional su-
peroxide dismutating centers. These complexes show elevated efficiency in pro-
tecting red blood cells against asbestos-induced oxidative injury in vitro. Accor-
ding to the same authors, the Cu–rutin complex was found to be the most effect-
tive anti-oxidant against asbestos-induced lipid peroxidation in pulmonary tissue 
in vivo.56 Moridani et al.57 found that the Fe(III) complexes of flavonoids were 
much more effective than the free flavonoids in protecting isolated rat hepatocy-
tes against hypoxia–reoxygenation injury. By using the 1,1-diphenyl-2-picrylhy-
drazyl radical scavenging method, de Souza and de Giovani58 found antioxidant 
activities of the quercetin, rutin, galangin, and catechin complexes more effect-
tive then free flavonoids. Afanas'ev et al.59 found that Fe(II)– and Cu(II)–rutin 
complexes were more efficient free radical scavengers in vitro and ex vivo. These 
complexes decreased the production of oxygen radicals by xanthine oxidase, rat 
liver microsomes and the rat peritoneal macrophages, as well as the generation of 
oxygen radicals by bronchioalveolar cell from bleomycin-treated rats by 2–30 ti-
mes compared to the parent rutin.59 The anti-oxidative activities of morin and its 
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Pd(II)- and Pt(II)-complexes were also investigated.60 The anti-oxidative effects 
(scavenging superoxide radicals) of the complexes were greater than that of mo-
rin itself, while the Pt(II)-complex exhibited stronger scavenging efficacy than the 
Pd(II)-complex. Both the Pd(II)- and Pt(II)-complexes showed an inhibitory ef-
fect on lipid peroxides which was greater than that of free morin.60 Due to anti-
oxidative mechanisms, morin complexes with La(III), Gd(III) and Lu(III) ions 
against three bacterial strains, i.e., Escherichia coli, Klebsiella pneumoniae and 
Staphylococcus aureus showed inhibitory action.61 Rare earth metal(III) comple-
xes with quercetin can bind to DNA thereby changing its transcription and re-
pressing the growth of tumor cells.62 
Complexes of flavonoids play an important role in limiting metal bioavaila-
bility and suppressing metal toxicity. For example, aluminum has been impli-
cated in neurological and bone disorder. The complexation of Al(III) by quer-
cetin reduces aluminum overload in the diet.63 By forming complexes, flavo-
noids appear to be a suitable antidote for heavy metal poisoning in vivo.64 Quer-
cetin, as an active biological ligand, might be an appropriate Mo(VI) chelator in 
the case of molybdenum deficiency caused by irradiation, since the use of molyb-
denum salts is undesirable because of their high toxicity.65 
Physico–chemical features of metal–flavonoid complexes 
Understanding the mechanisms of chelation of flavonoids by metal ions per-
mits a better understanding of their complex anti-oxidant properties. Therefore, 
many metal–flavonoid complexes have been synthesized and characterized in the 
past several years.66–74 Elemental and thermal analyses, conductivity and cyclic 
voltammetry, as well as IR, Raman, 1H-NMR, 13C-NMR, UV–Vis and fluores-
cence spectroscopy have been used to asses relevant interactions of flavonoids 
and metal ions, the chelation sites, the dependence of the complex structure on 
the metal/ligand ratio, the capability of flavonoids in binding metal ions, etc. 
However, data on the composition, structure and complex-formation features are 
sometimes incomplete and contradictory. The outcome largely depends on the 
experimental condition and the type of assay employed. 
Metal–flavonoid complex compounds are the subject of our longtime res-
earch during which their properties, composition, complex formation features, 
stability constants, as well as analytical appraisal were investigated.75–111 Start-
ing in the early 1980's until now, approximately 40 complexes of flavonoids from 
different flavonoids subclasses (rutin, quercetin, 3-hydroxyflavone, morin and hes-
peridin, Fig. 2) with a number of metal ions or metal groups have been invest-
tigated. Considering the importance of metal chelation for the understanding of 
the anti-oxidant behavior of flavonoids, our aim is to give a personal account on 
the development of the field through a retrospective of our own research. In ad-
dition, analytical methods suitable for routine analysis involving the spectropho-
tometric determination of flavonoids via complexing reactions are also reported. 
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Fig. 2. The investigated flavonoids: a) rutin 
(3,3’,4’,5,7-pentahydroxyflavone-3-rhamnoglu-
coside), b) quercetin (3,3',4',5,7-pentahydroxyfla-
vone), c) morin (2',3,4',5,7-pentahydroxyflavone), 
d) 3-hydroxyflavone (3-hydroxy-2-phenyl-4H- 
-1-benzopyran-4-one or 3-hydroxy-2-phenylchro-
mone) e) hesperidin (hesperitin 7-rhamnogluco-
side). Rutin and hesperidin are glucosides con-
taining sugar moiety. 
UV–Vis spectra 
Metal–flavonoid chelates are usually colored. In the presence of metal ions, 
a bathochromic shift is typically observed in the absorption spectra of flavonoids. 
The reaction with AlCl3, described for the first time in 1962,3 is actually the 
earliest presented complexing reaction of flavonoids with aluminum as the cen-
tral ion and flavone as the ligand. Already then it was observed that complex for-
mation causes a bathochromic shift in both absorption bands, I and II, and that 
the shift is reversed by increasing the acidity of the medium. A similar behavior is 
observed for all flavonoid subclasses possessing 5-hydroxy-4-keto, 3-hydroxy-4-keto 
and/or o-dihydroxy groups, suggesting that these moieties are important for che-
lation. This red shift is caused by the increased conjugative effect when the com-
plexes are formed to give a new ring (Fig. 3). 
The site of the central ion 
In each flavonoid molecule, there are three domains that can likely interact 
with metal ions, i.e., the 3',4'-dihydroxy group located on the B ring, the 3-hyd-
roxy or 5-hydroxy and the 4-carbonyl groups in the C ring. Generally, the chela-
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ting properties of flavonoids toward metal ions have been attributed to the pre-
sence of the 3- or 5-hydroxypyran-4-one, rather than the ortho-hydroxyl groups 
in the B ring.112 Our own IR spectroscopic results the Pd(II)–quercetin102 (Fig. 4) 
and UO2(II)–rutin101 (Fig. 5) complexes also confirm that the benzoyl moiety is 
the major site for metal chelation. There are, however, studies proposing the cate-
chol moiety as the major site for metal chelating.54,66 The results of Bodini et 
al.113 indicate that coordination to the catechol group of quercetin is the strongest 
for iron, even in acidic media. Cornard and Merlin70 assert the opposite, that in 
acidic media the ortho-dihydroxyl groups of quercetin are never involved in com-
plexation with Al(III). The same authors found two binding sites in the Al(III)–quer-
cetin complex; the first one involved in complex formation is the 3-hydroxychro-
mone and the second one is the ortho-hydroxy groups, which are strongly depen-
dent on the medium and pH. Depending on the experimental conditions, as well 
as with an excess of the metal ion, Torreggiani et al.72 also found that two chelat-
ing processes occurred consecutively, implicating two binding sites in the Cu(II)–quer-
cetin complex. Based on 1H-NMR, DTA curves and fluorescence spectroscopy, 
Tang et al.60 proposed the site of metal ion in chelation given in Fig. 6. 
Fig. 3. The red shift of band I and band II in 
morin (HL) after reaction with Pt(II).60 
 
Fig. 4. Formation of uranyl–rutin complex in a 1:1 stoichiometric ratio: a) rutin, b) complex. Favored 
metal site is 5-hydroxypyran-4-one, rather than the ortho-hydroxyl groups in the B ring.101 
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Fig. 5. Composition of the Pd(II)–quercetin complex. Favored metal site is 
3-hydroxypyran-4-one, as confirmed by IR spectroscopy.102 
Fig. 6. Probable structure of M(II)–morin complexes 
M = Pt(II), Pd(II) and Zn(II). The structure is sug-
gested due to the fixation of ring B caused by the ef-
fect of coordination after the complex was formed.60 
Composition of the complexes 
Based on our research, only mononuclear complexes (with one central ion) 
were formed under the investigated experimental conditions (water–alcoholic so-
lution, neutral or acidic media, maximum concentration of 0.0025 mol dm–3 for 
rutin, quercetin, morin and 3-hydroxyflavone and 0.0015 mol dm–3 for hesperi-
din). The maximum number of flavonoids in a complex never exceeded two. 
Though complexes comprising a greater number of flavonoids as ligands are 
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sterically unfavorable, Zhou and co-workers62 found by fluorescence spectrosco-
py 1:3 complexes of quercetin with eight rare-earth metal ions as the central ions. 
The stoichiometric composition of flavonoid complexes is typically determi-
ned by the following methods: the method of continual variation of equimolar 
and non-equimolar solutions, the molar-ratio method, the Bent–French and Nach 
methods.114,115 According to longtime experience, the most reliable results were 
obtained by the method of continual variation of equimolar solutions, while the 
method of continual variation of non-equimolar solutions is not recommended for 
metal–flavonoids complexes because of low reproducibility. It was also found 
that the Bent–French method is not sufficiently accurate for complexes with a 1:2 
stoichiometric ratio, but is acceptable for complexes with a 1:1 composition. Ac-
cording to recent literature, these methods were not widely utilized by other au-
thors (only the molar ratio method and method of continual variation were used 
by Cornard and co-authors),6971 but we find them still suitable taking into ac-
count their simplicity and inexpensiveness. The compositions of the investigated 
flavonoid complexes, as well as the methods used, are presented in Table I. 
TABLE I. Composition of the metal–flavonoid complexes. MR: Mole ratio method, B–F:  
Bent–French method 
Flavonoid Method Metal ion Metal/flavonoid pH Ref. 
Job, MR Cu(II) 1:2 6.1 78 
MR, B–F Zn(II) 1:1 6.2 79 
MR, Nach, Job Pb(II) 1:2 4.5 80 
MR, Nach, Job Ni(II) 1:2 6.2 82 
MR, Nach Co(II) 1:1 5.0 83 
B–F, Job, MR 24MoO
 1:1 6.3 91 
MR 24WO
 1:2 7.0 92 
Job, MR Eu(III) 1:2 5.0 98 
Job, MR UO2(II) 1:1 6.8 101 
Job Pd(II) 1:2 8.2 103 
Rutin 
Job, MR 2242 )OTiO(C
 1:2 6.4 107 
MR, Nach Ni(II) 1:1 5.0 81 
MR, Nach Co(II) 1:1 5.0 84 
Job, MR Pd(II) 1:1 6.2 102 
Quercetin 
Job, MR 2242 )OTiO(C 1:2 6.4 109, 111 
Job, MR Cu(II) 1:2 5.8 76 
Job, MR, Nach Zn(II) 1:2 5.5 77 
Job 24WO  1:2 5.2 97 
Job Pd(II) 1:1 5.5 106 
Job, MR 2242 )OTiO(C 1:2 4.3 110 
Morin 
MR, B–F Ba(II) 1:1 4.2 85 
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TABLE I. Continued 
Flavonoid Method Metal ion Metal/flavonoid pH Ref. 
Job Zn(II) 1:1 5.8 75 
Job, MR, Nach Pb(II) 1:1 6.1 93 
Job, MR Ni(II) 1:1 6.1 95 
Job Co(II) 1:1 6.2 86 
Job, MR 24MoO
 1:2 6.3 90 
Job 24WO
 1:2 8.6 94 
Job Eu(III) 1:2 5.7 96 
Job, MR, B–F UO2(II) 1:1 3.5 88 
Job, MR 2242 )OTiO(C
 1:2 5.0 108 
3-Hydroxyflavone 
Job, MR Mn(II) 1:1 6.3 87 
Job, MR Cu(II) 1:2 5.7 105 
Job, MR UO2(II) 1:2 3.7 104 
Job, MR Al(III) 1:1 3.7 100 
Hesperidin 
Job, MR Zr(IV) 1:1 3.6 99 
The role of pH in complex formation 
Flavonoids are weak polybasic acids that tend to protonate.114 Therefore, pH 
has a considerable impact on complex formation. According to our results, com-
plexes with the highest coordination number are typically formed in slightly aci-
dic or neutral pH, rarely in basic media. The optimal pH for complex formation, 
although strongly dependent on the features of the metal ion, is around pH 6. Com-
plex formation at pH values lower than 3.0 is difficult because the flavonoids are 
predominantly present in their undissociated form. Although high pH values fa-
vor deprotonation of flavonoids and, consequently, more complex species, at hi-
gher pH values metal ions are often involved in side reaction (hydrolysis) and 
hydroxo-complexes are formed.75111 
Complexation with flavonoids as unidentate or bidentate ligands leads to the 
formation of complexes that contain protons in addition to the metal ion and li-
gand (so-called protonated complexes) which tend to dissociate at higher pH va-
lues. Thus, the bathochromic shift that can be observed in the absorption spectra 
of metal–flavonoid complexes at higher pH values can be attributed to the disso-
ciation of the protonated complexes, rather than the formation of complexes with 
different stoichiometric compositions.102109 The absorption spectra of the titanyl-
oxalato–quercetin complex at different pH values are presented in Fig. 7. The ma-
jority of the investigated metal–flavonoid complexes follow this pattern.102109 
Stability of complexes 
Several methods for spectrophotometric determination of the stability cons-
tants of metal–ligand complexes have been described, such as the Sommer, 
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Bent–French and Nach method, the method of continual variation of equimolar 
solutions, the molar-ratio method and the Bjerrrum method.114115 We found the 
Bjerrum method to be the most appropriate for metal–flavonoid complexes, hav-
ing satisfactory reproducibility and accuracy. The method was modified and sim-
plified by Malešev and the adopted method (denoted with Bjerrum* in Table II), 
described in detail in the literature,91,94,100,102 was extensively used in our re-
search. The stability constant of approximately twenty metal–flavonoid comple-
xes were calculated using this method, Table II (note that only one value for the 
stability constant is presented although two or more methods were applied in the 
study, but gave approximately equal results). 
 
Fig. 7. Absorption spectra of the titanyloxalato–quercetin complex obtained at different pH values; 
curves 1–12: pH: 3.6 (1), 4.3 (2), 5.0 (3), 5.6 (4), 6.8 (6), 7.2 (7), 8.2 (8) 9.2 (9), 10.0 (10), 12.2 
(11), 10.6 (12). The bathochromic shift is due to dissociation of the complex.109 
In general, the majority of the investigated complexes can be characterized 
as moderately (5 < log < 10) or highly (log > 10) stable. It is interesting to note 
that in the highly stable complexes, the central ion is typically an anion, i.e., tita-
nyloxalate 2242 )OTiO(C  and 
2
4WO  in complexes with rutin, morin and 3-hydroxy-
flavone and 24MoO  in the complex with 3-hydroxyflavone, rather than a cation. 
This is in discordance with the crystal field theory, which describes bonding in tran-
sition metal complexes and states that the interactions between ligand and metal 
are partly electrostatic. However, the molecular orbital theory allows overlapping 
of atomic orbitals with the same symmetry between the central ion and the li-
gands. Thus, bonding in metal–flavonoid complexes probably occurs by electron 
transfer from the d orbital of the metal ion to the * orbital of the flavonoid.115 
For several investigated rutin complexes, the values of the thermodynamic pa-
rameters for complex formation were determined and they imply that the reaction 
between a flavonoid and a metal ion occurs spontaneously at room temperature.111 
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TABLE II. Stability constants of metal–flavonoid complexes. Bjerrum* denotes Bjerrum's modi-
fied method 
Flavonoid Method Metal ion Stability constant log pH 
Sommer, Nach Cu(II) 10.76 6.1 
Nach, B–F Zn(II) 4.68 6.2 
Sommer, Nach Pb(II) 13.81 4.5 
MR, Nach Ni(II) 8.95 6.2 
Nach, MR Co(II) 6.04 5.0 
B–F, Bjerrum* 24MoO
 8.01 4.0 
Bjerrum* 24WO
 13.44 4.0 
Bjerrum* Eu(III) 10.59 5.0 
Bjerrum* UO2(II) 6.57 4.0 
Bjerrum* Pd(II) 10.15 8.0 
Rutin 
Bjerrum* 2242 )OTiO(C
 10.80 6.5 
MR Ni(II) 5.57 5.0 
Sommer Co(II) 4.87 5.0 
Bjerrum* Pd(II) 6.05 5.0 
Quercetin 
Bjerrum* 2242 )OTiO(C  11.84 6.5 
Sommer Cu(II) 4.94 5.8 
Sommer Zn(II) 6.74 5.5 
Bjerrum* 24WO  11.6 3.0 
Bjerrum* Pd(II) 4.55 4.0 
Bjerrum* 2242 )OTiO(C  7.35 8.0 
Morin 
MR, B–F Ba(II) 4.55 4.2 
Sommer Zn(II) 8.51 5.8 
Nach Pb(II) 7.74 6.1 
Nach Ni(II) 7.63 6.1 
B–F, Nach Co(II) 10.87 6.2 
Bjerrum* 24MoO
 15.13 6.3 
Bjerrum* 24WO
 16.45 4.0 
Bjerrum* Eu(III) 13.47 6.0 
B–F, Bjerrum* UO2(II) 8.68 4.0 
Bjerrum* 2242 )OTiO(C
 16.65 5.0 
B–F, Bjerrum* Mn(II) 5.43 6.0 
3-Hydroxyflavone 
B–F, Bjerrum* Cd(II) 5.90 6.2 
Bjerrum* Cu(II) 5.78 7.0 
Bjerrum* UO2(II) 7.00 6.0 
Hesperidin 
Bjerrum* Al(III) 4.54 5.0 
Analytical appraisal 
Due to their significant health benefits, sensitive analytical methods are re-
quired for the quantitative determination of flavonoids in crude plant materi-
als/extracts, plant-based beverages and pharmaceutical preparations. Until now, a 
number of analytical techniques have been described for the quantification of fla-
vonoids. Liquid chromatography is currently the most commonly applied method 
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for routine determination of flavonoids. Reversed phase RP-HPLC approaches 
established in the late 1980s116 aim at the separation, identification and quantiza-
tion of flavonoids in crude plant materials/extracts and plant-based beverages.117–126 
Given that metal–flavonoid chelates are usually colored and absorb at a dif-
ferent wavelength, the complexing reactions of flavonoids with metal ions can be 
optimized and utilized for the quantitative determination by indirect spectropho-
tometric methods. By measuring the absorbance of the newly formed colored 
complex, the amount of the complex-forming constituent (metal ion or ligand fla-
vonoid) can be quantified. Flavonoid-complexing reactions are particularly suita-
ble for analytical purpose because the solutions of the complexes show excellent 
characteristics for detection by spectrophotometric techniques (intensive color, 
clear, translucent and rather stable in time).75–111 The intensity and the hue of the 
color of the complexes depend strongly on the chemical properties of the flavor-
noid, in particular the number and the position of the hydroxyl groups in the 
flavonoid molecules, as well as the properties of the metal ion. The length of the 
conjugated -bond system which includes the reactive groups affects conside-
rably the absorption intensity and hence sensitivity. 
Several official methods for flavonoid determination recommend the emp-
loyment of complexing reactions. For example, the Romanian Pharmacopoeia X 
established the usage of AlCl3 as a colorimetric reagent for the quantitative ana-
lysis of flavonoids in Cynarae folium,127 and a general color test for identifica-
tion of flavonoids in extracts obtained from stems, leaves and flowers prescribes 
the reaction with 5 % FeCl3.128 During the late 1960s and early 70s, interactions 
of flavonoids with metal ions were investigated for analytical purposes.129–145 In 
these articles, chelating reactions of flavones and flavonols were predominantly 
described, emphasizing their potential for analytical determination of metal ions 
in the atmosphere, natural water, biological materials and alloys. The following 
detection limits for some of the metal ions were achieved: 5.5 ppm for Zr(IV), 
2.8 ppm for Mo(VI), 3.7 ppm for W(IV) and 0.5 ppm for Fe(III) based on com-
plexing reaction with rutin.145 To improve the sensitivity and selectivity of metal 
determination, multi-ligand complexes incorporating a metal, flavone and some 
other ligands (antipyrine, 4ClO , 
2
4SO ) were synthesized.145 Being suitable for 
metal determination, complexing reactions of flavonoids have been extensively 
investigated during last ten years.146153 For this purpose, quercetin and morin 
were the most widely used flavonoids for the determination of Al(III), Cr(III), 
W(IV), Zn(II), Ti(IV), Fe(III) and Mo(VI). 
Determination of flavonoids via colored complexing reactions 
Numerous complexing reactions have been optimized and adjusted for spec-
trophotometric determination of the parent flavonoid.88–109 Alcohol–water mix-
tures were used as the solvent. The composition of the solvent was optimized to 
achieve complete dissolution of both components, and ranged typically between 
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50 to 80 % ethanol (methanol for hesperidin complexes). The ionic strength and 
pH were adjusted to a constant value. Parameters, such as linearity, interval 
(range), specificity, estimated limit of detection (LOD), estimated limit of quanti-
zation (LOQ), recovery (R, %), precision or relative standard deviation (RSD, %) 
were established. 
Generally, the Beer law was obeyed in the range from 106 to 10–3 mol dm3 
for the considered flavonoid, with excellent linearity. Among a variety of selec-
ted metal salts, potassium titanyloxalate is particularly suitable for analytical 
purposes.109 For the determination of rutin via the titanyloxalato complex, the 
best detection limit LOD = 0.67 g ml1 was obtained.107 
Complexing reactions were also optimized in an attempt to develop a simple, 
rapid and inexpensive method for the routine determination of flavonoids in com-
mercially available pharmaceutical preparations (Table III). Using the proposed 
method, it was possible to eliminate the matrix interference since the flavonoid 
molecules exclusively form the complex. A good selectivity (ability to accurately 
measure an analyte in the presence of other substances that may be present in the 
sample matrix) with respect to other constituents in the sample matrix (tablet ex-
cipients and diluents, other active principles) was achieved by the proposed as-
says. The low values of the obtained RSD (less then 3 %) and recovery lying in 
the stated range (Ph EUR 97), indicate good application of the method for flavor-
noid determination in oral dosage forms. 
TABLE III. Spectrophotometric determination of rutin and quercetin in oral dosage forms, and hes-
peridin in orange juices via the complexing reaction 
Rutin Quercetin Hesperidin in orange juice 
Metal ion Recovery 
% 
RSD 
% 
Recovery 
% 
RSD 
% Trade name
Found
mg l-1 SD 
Ref. 
Al(III) – – – – “Happy day”
”Bravo” 
268
6.79 
168 
7.88 100 
Pd(II) 102.5 0.57 – – – – – 103 
UO2(II) 97.9 0.75 – – – – – 101 
2
242 )OTiO(C 97.3 0.87 104.5 2.80 – – – 107, 111 
However, the selectivity with respect to other compounds which are structu-
rally/chemically related to flavonoids is low in complex matrices, such as Ginkgo 
biloba preparations. However, in mixtures of flavonoids and other relevant com-
ponents containing one component in a relatively large excess, the same proce-
dure can be applied. For example, the content of hesperidin in orange juice is si-
gnificantly higher than other flavonoids. Thus, using the complexing reaction 
with Al(III), it was possible to determine hesperidin in orange juice.100 Since the 
amount of hesperidin differs significantly in different species, even in one and 
the same plant material, depending strongly on the region of growth and the sea-
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son, the content of hesperidin is usually not declared by producers, but the con-
centration obtained in the investigated brands of orange juice with this particular 
reaction, corresponds to those found by other authors.154 
CONCLUSIONS 
The overall anti-oxidant action of flavonoids is achieved through synergy 
between a direct reaction with free radicals and the chelation of metal ions which 
are responsible for the production of reactive oxygen species. To unravel the ori-
gin of their potent biological action, many metal–flavonoid complexes have been 
synthesized and characterized. Our research in metal–flavonoid complexes co-
vers approximately 40 complexes of five flavonoids (rutin, quercetin, 3-hydroxy-
flavone, morin and hesperidin) with a number of metal ions or metal groups. Only 
mononuclear complexes were formed under the employed experimental conditi-
ons. The 3- or 5-hydroxy group and the 4-carbonyl group in the C ring are main 
metal complexing domains which interact with metal ions. The majority of the 
investigated complexes are moderate (5 < log < 10) or highly stable (log > 10) 
complexes. Some complexing reactions were utilized to develop simple methods 
for routine determination of rutin, quercetin or hesperidin in commercially avail-
able pharmaceutical preparations or beverages. 
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